1. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 6 (June 2016) Authors: Vansteenkiste, Johan F; Cho, Byoung Chul; Vanakesa, Tonu; De Pas, Tommaso; Zielinski, Marcin; Kim, Moon Soo; Jassem, Jacek; Yoshimura, Masahiro; Dahabreh, Jubrail; Nakayama, Haruhiku; Havel, Libor; Kondo, Haruhiko; Mitsudomi, Tetsuya; Zarogoulidis, Konstantinos; Gladkov, Oleg A; Udud, Katalin; Ta... Journal: Lancet oncology Issue: Volume 17:Issue 6(2016:Jun.) Page Start: 822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗